[1]
Mohite, S.; Sanches, M.; Teixeira, A.L. Exploring the evidence implicating the Renin- Angiotensin System (RAS) in the physiopathology of mood disorders. Protein Pept. Lett., 2020, 27(6), 449-455.
[2]
Machado, T.C.G.; Guatimosim, C.; Kangussu, L.M. The renin-angiotensin system in Huntington’s disease: Villain or hero? Protein Pept. Lett., 2020, 27(6), 456-462.
[3]
Kangussu, L.M.; Marzano, L.A.S.; Souza, C.F.; Dantas, C.C.; Miranda, A.S.; Simões E Silva, A.C. The renin-angiotensin system and the cerebrovascular diseases: Experimental and clinical evidence. Protein Pept. Lett., 2020, 27(6), 463-475.
[4]
de Melo, L.A.; Almeida-Santos, A.F. Neuropsychiatric properties of the ACE2/Ang-(1-7)/Mas pathway: A brief review. Protein Pept. Lett., 2020, 27(6), 476-483.
[5]
Ribeiro, V.T.; de Souza, L.C.; Simões E Silva, A.C. Renin-angiotensin system and Alzheimer’s disease pathophysiology: From the potential interactions to therapeutic perspectives. Protein Pept. Lett., 2020, 27(6), 484-511.